Journal Information

Statistics

Follow this link to access the full text of the article

Original article
A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia
Hemant Misraa,
Corresponding author
hmisra@prolongpharma.com

Corresponding author at: Clinical Development, 300B Corporate Court, South Plainfield, NJ 07080, United States.
, James Bainbridgea, John Berrymana, Abraham Abuchowskia, Kenneth Mauricio Galvezb, Luis Fernando Uribec, Angel Luis Hernandezd, Nestor Rodolfo Sosae
a Prolong Pharmaceuticals, South Plainfield, United States
b Hospital Pablo Tobon Uribe, Medellin, Colombia
c Fundación Reina Isabel, Cali, Colombia
d Fundación BIOS, Barranquilla, Colombia
e Pan American Medical Research Institute, Pamri, Panama
Read
1077
Times
was read the article
341
Total PDF
736
Total HTML
Share statistics
Article information
ISSN: 15168484
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 May 195 13 208
2024 April 46 23 69
2024 March 41 20 61
2024 February 47 29 76
2024 January 73 28 101
2023 December 59 31 90
2023 November 76 54 130
2023 October 45 38 83
2023 September 44 39 83
2023 August 19 15 34
2023 July 22 15 37
2023 June 28 14 42
2023 May 28 14 42
2023 April 13 8 21
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy